Agilent Technologies, Inc. (A) vs Natera, Inc. (NTRA)

Agilent Technologies, Inc. and Natera, Inc. are both Diagnostics & Research companies. Natera, Inc. is the larger, with a market value of $59.2B against $49.0B — 1.2× the size. Natera, Inc. has negative trailing earnings, so its P/E is not meaningful; Agilent Technologies, Inc. trades at 33.9×. Natera, Inc. grew revenue faster over the last twelve months: 37.8% against 8.60%. Agilent Technologies, Inc. has the higher net margin (19.5% vs −7.11%) and the higher return on invested capital (11.1% vs −22.3%). Across the 20 metrics below, Agilent Technologies, Inc. leads on 15 and Natera, Inc. on 5.

Valuation

Metric A NTRA Diagnostics & Research median
P/E 33.95 n/m 33.95
P/S 6.61 21.84 4.87
P/B 6.62 32.45 3.12
Price to free cash flow 38.40 702.06 34.02
EV/EBITDA 26.50 n/m 25.20
EV/Sales 6.87 21.57 5.66
Earnings yield 2.95% (0.33%) (1.75%)
Free cash flow yield 2.60% 0.14% (0.13%)

Profitability

Metric A NTRA Diagnostics & Research median
Gross margin 53.83% 65.23% 50.89%
Operating margin 22.23% (10.70%) (8.57%)
Net margin 19.53% (7.11%) (6.37%)
Free cash flow margin 17.19% 3.11% 0.00%
Return on equity 20.97% (12.54%) (2.92%)
Return on assets 11.00% (8.71%) (6.71%)
Return on invested capital 11.07% (22.34%) 0.00%

Growth

Metric A NTRA Diagnostics & Research median
Revenue growth (TTM) 8.60% 37.82% 7.69%
EPS growth (last fiscal year) 3.16% 0.65% —
Revenue growth, 5-year CAGR 5.41% 42.61% 7.40%
Net income growth, 5-year CAGR 12.63% 0.00% 0.00%

Health

Metric A NTRA Diagnostics & Research median
Debt to equity 0.50 0.04 0.11
Current ratio 2.05 3.00 2.02
Net debt to EBITDA 0.71 3.74 0.78

Dividend

Metric A NTRA Diagnostics & Research median
Dividend yield 0.70% — 0.70%
Payout ratio 0.23 0.00 0.00

Size

Metric A NTRA Diagnostics & Research median
Market cap 49.02b 59.17b 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack